Prescription Drug Prices Drop 3.1% in a Year

According to the Bureau of Labor Statistics, prescription drug prices fell 0.8% in July and have not risen in any month this year. This decline is a significant reversal of the typically high cost of prescription drugs. The Trump administration has attributed the price drop to its efforts, including the TrumpRx website, which connects patients with discounted cash prices for certain drugs. However, other factors, such as Medicare negotiations and market forces, may also be contributing to the decline.

The Inflation Reduction Act, which took effect in January, allows Medicare to negotiate prices for certain costly drugs, with negotiated prices as much as 79% below list prices. Additionally, changes in what Medicare pays pharmacies can impact the prescription drug Consumer Price Index. Geoffrey Joyce, a USC health economist, noted that while TrumpRx makes discounts easier to find, much of the decline is being driven by market forces, including heated competition in the market for certain drugs.

The decline in prescription drug prices may not necessarily translate into relief for consumers, given the complexity of drug pricing and payments. Many Americans are still worried about affording their medications, with six in 10 saying they were concerned about the cost of their medications, and four in 10 saying they had not taken medication as prescribed due to cost.